Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMID 8040673)

Published in J Clin Oncol on August 01, 1994

Authors

J R Geyer1, P M Zeltzer, J M Boyett, L B Rorke, P Stanley, A L Albright, J H Wisoff, J M Milstein, J C Allen, J L Finlay

Author Affiliations

1: Children's Hospital and Medical Center, Seattle, WA.

Articles citing this

Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections. Cancer Chemother Pharmacol (2014) 1.78

Reduced bone density at completion of chemotherapy for a malignancy. Arch Dis Child (1999) 1.50

Pediatric brain tumors: current treatment strategies and future therapeutic approaches. Neurotherapeutics (2009) 1.40

Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy. Neuro Oncol (2008) 1.33

Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma. Neuro Oncol (2008) 1.33

Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma. Br J Cancer (2009) 1.14

Chemotherapy for malignant brain tumors of childhood. J Child Neurol (2008) 1.14

Initial management of childhood brain tumors: neurosurgical considerations. J Child Neurol (2008) 1.05

Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology. Neuro Oncol (2011) 1.03

Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy. Neuro Oncol (2012) 0.97

Aggressive infantile embryonal tumors. J Child Neurol (2008) 0.96

Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth. Cancer Res (2008) 0.94

The history of ependymoma management. Childs Nerv Syst (2009) 0.92

Pilot Study of Intensive Chemotherapy With Peripheral Hematopoietic Cell Support for Children Less Than 3 Years of Age With Malignant Brain Tumors, the CCG-99703 Phase I/II Study. A Report From the Children's Oncology Group. Pediatr Neurol (2015) 0.90

Medulloblastoma with extensive nodularity: a variant occurring in the very young-clinicopathological and immunohistochemical study of four cases. Childs Nerv Syst (2003) 0.88

New chemotherapy strategies and biological agents in the treatment of childhood ependymoma. Childs Nerv Syst (2009) 0.88

M1 Medulloblastoma: high risk at any age. J Neurooncol (2008) 0.87

Advances in treatment of pediatric brain tumors. NeuroRx (2006) 0.87

Comparative genomic hybridization and histological variation in primitive neuroectodermal tumours. Br J Cancer (1999) 0.85

Treatment developments and the unfolding of the quality of life discussion in childhood medulloblastoma: a review. Childs Nerv Syst (2014) 0.85

Treatment outcome and patterns of failure in patients of pinealoblastoma: review of literature and clinical experience from a regional cancer centre in north India. Childs Nerv Syst (2015) 0.83

Efficacy of vincristine and etoposide with escalating cyclophosphamide in poor-prognosis pediatric brain tumors. Neuro Oncol (2006) 0.82

Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma. Cancer (2012) 0.81

Decreased morbidity and mortality of autologous hematopoietic transplants for children with malignant central nervous system tumors: the 'Head Start' trials, 1991-2009. Bone Marrow Transplant (2016) 0.80

Surgical considerations in fourth ventricular ependymoma with the transcerebellomedullary fissure approach in focus. Childs Nerv Syst (2009) 0.75

Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy? J Cancer Res Clin Oncol (2017) 0.75

Articles by these authors

Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res (1999) 4.26

Fringe is a glycosyltransferase that modifies Notch. Nature (2000) 4.09

High incidence of secondary brain tumours after radiotherapy and antimetabolites. Lancet (1999) 3.63

The sodium-potassium adenosine triphosphatase: pharmacological, physiological and biochemical aspects. Pharmacol Rev (1975) 3.51

Nonaccidental head injury in infants--the "shaken-baby syndrome". N Engl J Med (1998) 3.46

Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol (1999) 3.08

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. Lancet (1998) 3.07

Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood (2000) 2.92

Hidden rheumatoid factors with specificity for native gamma globulins. Arthritis Rheum (1966) 2.87

Central neurofibromatosis with bilateral acoustic neuroma: genetic, clinical and biochemical distinctions from peripheral neurofibromatosis. Neurology (1980) 2.77

Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945. J Neurosurg (1998) 2.75

A comparison of single-dose dexmedetomidine or propofol on the incidence of emergence delirium in children undergoing general anaesthesia for magnetic resonance imaging. Anaesthesia (2014) 2.74

Selection and characterization of eight phenotypically distinct lines of lectin-resistant Chinese hamster ovary cell. Cell (1975) 2.72

MR of spinal cord ganglioglioma. AJNR Am J Neuroradiol (1998) 2.63

Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. N Engl J Med (1998) 2.59

Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia. N Engl J Med (1997) 2.38

Nestin expression in embryonic human neuroepithelium and in human neuroepithelial tumor cells. Lab Invest (1992) 2.30

Specific changes in the oligosaccharide moieties of VSV grown in different lectin-resistnat CHO cells. Cell (1978) 2.30

Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study. J Clin Oncol (2001) 2.30

High-frequency transfection of CHO cells using polybrene. Somat Cell Mol Genet (1986) 2.29

Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg (1997) 2.23

The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors. J Neuropathol Exp Neurol (1983) 2.22

Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. J Neurosurg (1998) 2.22

Mice lacking N-acetylglucosaminyltransferase I activity die at mid-gestation, revealing an essential role for complex or hybrid N-linked carbohydrates. Proc Natl Acad Sci U S A (1994) 2.21

A randomized, controlled study of a programmable shunt valve versus a conventional valve for patients with hydrocephalus. Hakim-Medos Investigator Group. Neurosurgery (1999) 2.19

Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia. Blood (1999) 2.18

mtDNA haplogroup X: An ancient link between Europe/Western Asia and North America? Am J Hum Genet (1998) 2.16

Translocation across Golgi vesicle membranes: a CHO glycosylation mutant deficient in CMP-sialic acid transport. Cell (1984) 2.15

Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group. J Clin Oncol (1999) 2.14

Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery (1994) 2.13

Glycosylation mutants of animal cells. Annu Rev Genet (1984) 2.12

Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Cancer Res (2001) 2.11

The polypeptides of influenza virus. V. Localization of polypeptides in the virion by iodination techniques. Virology (1971) 2.00

Complementation between mutants of CHO cells resistant to a variety of plant lectins. Somatic Cell Genet (1977) 1.98

Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital. J Clin Oncol (1997) 1.94

Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital. Leukemia (2000) 1.94

Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. J Clin Oncol (1995) 1.94

Malignant astrocytomas of the spinal cord. J Neurosurg (1989) 1.93

Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children's Cancer Group. Neurosurgery (1993) 1.92

Quality assessment of urinary organic acid analysis. Ann Clin Biochem (1994) 1.90

Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. J Clin Oncol (1999) 1.89

Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia. Blood (2000) 1.89

Outcome of treatment for childhood cancer in black as compared with white children. The St Jude Children's Research Hospital experience, 1962 through 1992. JAMA (1995) 1.89

Intramedullary spinal cord tumors in children under the age of 3 years. J Neurosurg (1996) 1.84

Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res (1996) 1.82

Cloning and expression of N-acetylglucosaminyltransferase I, the medial Golgi transferase that initiates complex N-linked carbohydrate formation. Proc Natl Acad Sci U S A (1990) 1.81

Traumatic basilar aneurysm after endoscopic third ventriculostomy: case report. Neurosurgery (1997) 1.80

Chinese hamster ovary cells selected for resistance to the cytotoxicity of phytohemagglutinin are deficient in a UDP-N-acetylglucosamine--glycoprotein N-acetylglucosaminyltransferase activity. Proc Natl Acad Sci U S A (1975) 1.79

Ventriculus terminalis of the conus medullaris: MR findings in children. AJNR Am J Neuroradiol (1995) 1.77

Relation between maternal diet and subsequent primitive neuroectodermal brain tumors in young children. N Engl J Med (1993) 1.76

Radical excision of intramedullary spinal cord tumors: surgical morbidity and long-term follow-up evaluation in 164 children and young adults. J Neurosurg (2000) 1.71

Communicating bronchopulmonary foregut malformations: classification and embryogenesis. J Pediatr Surg (1992) 1.68

A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome). Glycobiology (1999) 1.67

Survival of infants with malignant astrocytomas. A Report from the Childrens Cancer Group. Cancer (1995) 1.67

Intracranial ependymomas of childhood: long-term outcome and prognostic factors. Neurosurgery (1995) 1.66

Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements. Leukemia (2003) 1.64

Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology (1984) 1.64

Efficacy of a saccharin test for screening to detect abnormal mucociliary clearance. Br J Dis Chest (1984) 1.63

Medulloblastoma: clinical and biologic aspects. Neuro Oncol (1999) 1.61

Blood, brain, and cerebrospinal fluid concentrations of several antibiotics in rabbits with intact and inflamed meninges. Antimicrob Agents Chemother (1977) 1.61

Comparison of cisternal and lumbar CSF examination in leptomeningeal metastasis. Neurology (1992) 1.60

Immunolocalization of transforming growth factor beta 1, beta 2, and beta 3 and insulin-like growth factor I in premature cranial suture fusion. Plast Reconstr Surg (1997) 1.59

Modification of epidermal growth factor-like repeats with O-fucose. Molecular cloning and expression of a novel GDP-fucose protein O-fucosyltransferase. J Biol Chem (2001) 1.58

Mutism and pseudobulbar symptoms after resection of posterior fossa tumors in children: incidence and pathophysiology. Neurosurgery (1995) 1.57

WW6: an embryonic stem cell line with an inert genetic marker that can be traced in chimeras. Proc Natl Acad Sci U S A (1995) 1.56

Functional analysis of lymphoblast and cybrid mitochondria containing the 3460, 11778, or 14484 Leber's hereditary optic neuropathy mitochondrial DNA mutation. J Biol Chem (2000) 1.56

Spinal cord astrocytomas: long-term results comparing treatments in children. Childs Nerv Syst (1997) 1.55

Altered vitamin-D metabolism in pregnancy. Lancet (1977) 1.55

Possible involvement of cardiac Na+, K+-adenosine triphosphatase in the mechanism of action of cardiac glycosides. J Pharmacol Exp Ther (1969) 1.54

Studies in human lactation: milk volume and nutrient composition during weaning and lactogenesis. Am J Clin Nutr (1991) 1.53

Intracranial ependymomas in children. Int J Radiat Oncol Biol Phys (1990) 1.53

Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital. J Clin Oncol (1998) 1.52

Clinical evolution of Parkinson's disease and prognostic factors affecting motor progression: 9-year follow-up study. Eur J Neurol (2014) 1.52

Value of x ray examinations of the cervical spine. Br Med J (Clin Res Ed) (1983) 1.52

Congenital brain anomalies associated with the hypoplastic left heart syndrome. Pediatrics (1990) 1.52

Fringe modulation of Jagged1-induced Notch signaling requires the action of beta 4galactosyltransferase-1. Proc Natl Acad Sci U S A (2001) 1.51